Graf Akcie CBLI (Cleveland BioLabs Inc). Diskuze k akciím CBLI. Aktuální informace CBLI.

Základní informace o společnosti Cleveland BioLabs Inc (Akcie CBLI)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 49.04M
Hodnota podniku (EV) 35.29M
Tržby 43.645k
EBITDA -2.76
Zisk -2.64
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 808.60
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 1,123.53
P/FCF N/A
Price/Book -16.57
Účetní hodnota na akcii -0.19
Hotovost na akcii 0.15
FCF vůči ceně -5.49 %
Počet zaměstnanců 4
Tržba na zaměstnance N/A
Profit margin -912.16 %
Operating margin -6,347.87 %
Gross margin -162.82 %
EBIT margin -6,325.57 %
EBITDA margin -6,328.18 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst N/A %
EPS - Očekávaný růst příští rok N/A %
Return on assets -30.96 %
Return on equity -83.71 %
ROIC 91.42 %
ROCE -20.41 %
Dluhy/Equity -0.10
Čistý dluh/EBITDA 12.20
Current ratio 45.98
Quick Ratio 45.98
Volatilita 11.25
Beta 1.52
RSI 40.96
Cílová cena analytiků 40
Známka akcie (dle analytiků) N/A
Insider ownership 50.26 %
Institutional ownership 6.67 %
Počet akcií 15.479M
Procento shortovaných akcií 0.34 %
Short ratio 0.44 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2006
Země United States

Finanční výsledky akcie CBLI

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1.113$1.138$1.948$3.518$2.708$3.702
Cost Of Goods Sold------
Gross Profit$1.113$1.138$1.948$3.518$2.708$3.702
Research And Development Expenses$1.656$3.619$5.048$6.496$7.143$9.654
SG&A Expenses$1.818$2.319$2.501$3.378$6.356$8.47
Other Operating Income Or Expenses------
Operating Expenses$3.474$5.938$7.549$9.874$13.499$18.124
Operating Income$-2.361$-4.8$-5.601$-6.356$-10.791$-14.422
Total Non-Operating Income/Expense$-0.334$1.093$-4.242$3.766$-2.254$14.457
Pre-Tax Income$-2.695$-3.707$-9.843$-2.59$-13.045$0.035
Income Taxes------
Income After Taxes$-2.695$-3.707$-9.843$-2.59$-13.045$0.035
Other Income------
Income From Continuous Operations$-2.695$-3.707$-9.843$-2.59$-13.045$0.035
Income From Discontinued Operations------
Net Income$-2.647$-3.612$-9.707$-2.659$-12.638$1.629
EBITDA$-2.347$-4.782$-5.58$-6.292$-10.516$-13.581
EBIT$-2.361$-4.8$-5.601$-6.356$-10.791$-14.422
Basic Shares Outstanding1111111173
Shares Outstanding1111111173
Basic EPS$-0.23$-0.32$-0.87$-0.24$-1.79$0.60
EPS - Earnings Per Share$-0.23$-0.32$-0.87$-0.24$-1.79$0.60
# 2020 2019 2018 2017 2016 2015
Current Ratio1.90274.90864.32825.11023.54170.543
Long-term Debt / Capital-----0.4563
Debt/Equity Ratio-----2.3221
Gross Margin100100100100100100
Operating Margin-212.0344-421.7151-287.4625-180.6459-398.4539-389.5821
EBIT Margin-212.0344-421.7151-287.4625-180.6459-398.4539-389.5821
EBITDA Margin-210.7966-420.1182-286.3805-178.8424-388.2917-366.863
Pre-Tax Profit Margin-242.0166-325.7327-505.1768-73.6147-481.67770.9553
Net Profit Margin-237.7346-317.3444-498.1855-75.5702-466.639144.0073
Asset Turnover0.54660.2510.20230.22050.12970.3772
Inventory Turnover Ratio------
Receiveable Turnover2.93884.51943.51399.97564.291413.8545
Days Sales In Receivables124.19980.7633103.872336.589285.054126.3453
ROE - Return On Equity-273.7647-102.5845-132.8587-20.1612-86.74721.98
Return On Tangible Equity-273.7685-102.5849-132.8588-20.1612-86.74721.98
ROA - Return On Assets-132.2955-81.7626-102.2163-16.2326-62.47390.3603
ROI - Return On Investment-273.7684-102.5849-132.8588-20.1612-86.74721.0765
Book Value Per Share0.08710.31990.65681.16931.36870.6249
Operating Cash Flow Per Share0.17280.1822-0.1321.25243.63674.92
Free Cash Flow Per Share0.17640.1825-0.14881.26873.64514.9745